NOTV
Inotiv Inc
NASDAQ · Life Sciences Tools & Services
$0.42
+0.03 (+7.26%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.36M | 7.58M | 7.16M |
| Net Income | 774.0K | 561.6K | 611.5K |
| EPS | — | — | — |
| Profit Margin | 9.3% | 7.4% | 8.5% |
| Rev Growth | -3.1% | +2.1% | +7.8% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 2.50M | 2.72M | 2.15M |
| Total Equity | 11.73M | 11.99M | 11.98M |
| D/E Ratio | 0.21 | 0.23 | 0.18 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 1.18M | 989.7K | 1.05M |
| Free Cash Flow | 554.1K | 679.4K | 587.8K |